Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06259097 · ClinicalTrials.gov registry record · Phase 3
Different Medications to Induce Labor
A Phase 3 study of Pregnancy and Labor, sponsored by Icahn School of Medicine at Mount Sinai.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 300
- Enrollment target
- 2
- Study locations
NCT06259097 is a Phase 3 study of Pregnancy and Labor that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 300 participants, below the 871-participant average among 191 other Pregnancy trials with a reported enrollment target (66% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT06259097, a Phase 3 study of Pregnancy and Labor, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 300 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a randomized controlled trial examining whether the use of misoprostol or pitocin, in combination with a foley catheter, is more effective at inducing labor in patients with a gravid BMI that is considered obese.
Interventions
- DRUG Misoprostol
- DRUG Pitocin
Study Locations (2)
New York
- Mount Sinai Hospital - New York
- Bronx Care Health System - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2024-07-02 |
| Est. Completion | 2026-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06259097
The ClinicalTrials.gov registry entry for NCT06259097 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 871-participant average among 191 other Pregnancy trials with a reported enrollment target (66% lower). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pregnancy appearing as the primary indexed condition, and to 2 interventions - of which Misoprostol is the first listed.
NCT06259097 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06259097 about?
NCT06259097 is a clinical study titled "Different Medications to Induce Labor". This is a randomized controlled trial examining whether the use of misoprostol or pitocin, in combination with a foley catheter, is more effective at inducing labor in patients with a gravid BMI that is considered obese.
What is the current status of trial NCT06259097?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 300 participants. The study started on 2024-07-02. Estimated completion is 2026-04.
What conditions does trial NCT06259097 study?
This clinical trial studies the following conditions: Pregnancy, Labor.
What interventions are being tested in trial NCT06259097?
The interventions under investigation include: Misoprostol (DRUG), Pitocin (DRUG).
Who is sponsoring clinical trial NCT06259097?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06259097 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ropivacaine and Fentanyl for Labor Epidural Initiation
RECRUITING · Phase 3
-
Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in Pregnancy
RECRUITING · Phase 3
-
A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)
COMPLETED · Phase 3
-
The Safety and Effectiveness of Zidovudine in HIV-Infected Pregnant Women and Their Infants
COMPLETED · Phase 3
-
Induction With Misoprostol: Oral Mucosa Versus Vaginal Epithelium (IMPROVE)
COMPLETED · Phase 3
-
Comparison of Foley Balloon With or Without Traction for the Cervical Ripening
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.